News & Perspective

May 17, 2019

May 17, 2019

ASP Scan (Weekly) for May 17, 2019

Northern Ireland AMR plan
Rapid susceptibility tests
Unnecessary abx for respiratory infections
Antibiotics in school beef
UK veterinary stewardship policy
Improper prescribing in seniors
Resistant TB testing in China
Antibiotic production partnership
MCR-1 in chickens, camels
New CARB-X funding
Grant for TB research

Jan 18, 2019

Jan 18, 2019

ASP Scan (Weekly) for Jan 18, 2019

New CARB-X funding
VRE in Swiss hospitals
Antibiotic overprescribing in tots
Fast track for new C diff drug
Stewardship in pediatric surgery
MRSA decline in Germany
Antibiotic resistance on pig farms
Resistance genes in Bolivian river
Stewardship in English hospitals
Whiff of C diff in pets
Fecal microbiota transplant trial

Aug 17, 2018

Aug 17, 2018

Flu Scan for Aug 17, 2018

More H1N2v flu cases
Flu vaccine and narcolepsy
Avian flu outbreaks in Europe

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»